Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population

BMC Medical Genetics

Volumn 9, Issue , 2008, Pages

  Siraj, Abdul K ^a   Ibrahim, Muna ^a   Al Rasheed, Maha ^a   Abubaker, Jehad ^a   Bu, Rong ^a   Siddiqui, Shakaib U ^a   Al Dayel, Fouad ^a   Al Sanea, Osama ^b   Al Nuaim, Abdulrahman ^a   Uddin, Shahab ^a   Al Kuraya, Khawla ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^b SAAD SPECIALIST HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ARYLAMINE ACETYLTRANSFERASE; CYTOCHROME P450 1A1; DRUG METABOLIZING ENZYME; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; GLUTATHIONE TRANSFERASE T1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); XENOBIOTIC AGENT; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NAT2 PROTEIN, HUMAN; NQO1 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE);

ARTICLE; CANCER PREVENTION; CANCER RISK; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CONTROLLED STUDY; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK POPULATION; HISTOPATHOLOGY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; SAUDI ARABIA; THYROID PAPILLARY CARCINOMA; WILD TYPE; XENOBIOTIC METABOLISM; ARAB; CASE CONTROL STUDY; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; METABOLISM; PAPILLARY CARCINOMA; RISK FACTOR; THYROID TUMOR;

ARABS; ARYLAMINE N-ACETYLTRANSFERASE; CARCINOMA, PAPILLARY; CASE-CONTROL STUDIES; CYTOCHROME P-450 CYP1A1; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTATHIONE TRANSFERASE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); NAD(P)H DEHYDROGENASE (QUINONE); POLYMORPHISM, GENETIC; RISK FACTORS; THYROID NEOPLASMS; XENOBIOTICS;

EID: 48649106736     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-9-61     Document Type: Article

References (58)

1. Jemal A Murray T Ward E Cancer Statistics CA Cancer J Clin 2005, 54:8-29.
2. Memon A Varghese A Suresh A Benign thyroid disease and dietary factors in thyroid cancer: A case-control study in Kuwait Br J Cancer 2002, 86:1745-50. 10.1038/sj.bjc.6600303 12087461
3. Abdulmughni YA Al Hureibi KA Ghafoor MA Al Wadan AH Al Hureibi YA Thyroid Cancer in Yemen Saudi Med J 2004, 25:55-9. 14758381
4. Bazarbashi S DeVol E Young S Al-Eid H Arteh S Cancer Incidence Report Saudi Arabia 1999-2000 National Cancer Registry 2004.
5. Hundahl SA Fleming ID Fremgen AM Menck HR A national cancer database report on 53,856 cases of thyroid carcinoma treated in the U. S., 1985-1995 Cancer 1998, 83:2638-2648. 10.1002/ (SICI)1097-0142(19981215)83:12<2638::AID-CNCR31>3.0.CO;2-1 9874472
6. Ron E Lubin JH Shore RE Mabuchi K Modan B Pottern LM Schneider AB Tucker MA Boice JD Jr Thyroid cancer after exposure to external radiation: A pooled analysis of seven studies Radiat Res 1995, 141:259-77. 10.2307/ 3579003 7871153
7. Schlumberger M Cailleux AF Suarez HG de Vathaire F Irradiation and second cancers. The thyroid as a case in point CR Acad Sci III 1999, 322:205-13.
8. Lund E Galanti MR Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: An analysis of birth cohorts Cancer Causes Control 1999, 10:181-7. 10.1023/A:1008815327004 10454063
9. Sarasin A Bounacer A Lepage F Schlumberger M Suarez HG Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours C R Acad Sci III 1999, 322:143-9. 10196666
10. Laverdiere C Chiasson S Costea I Moghrabi A Krajinovic M Polymorphism G80A in the reduced folate carrier gene and its relationship to methotrexate plasma levels and outcome of childhood acute lymphoblastic leukemia Blood 2002, 100:3832-4. 10.1182/blood.V100.10.3832 12411325
11. Hishida A Matsuo K Hamajima N Ito H Ogura M Kagami Y Taji H Morishima Y Emi N Tajima K Associations between polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and susceptibility to malignant lymphoma Haematologica 2003, 88:159-66. 12604405
12. Matsuo K Hamajima N Suzuki R Ogura M Kagami Y Taji H Yasue T Mueller NE Nakamura S Seto M Morishima Y Tajima K Methylenetetrahydrofolate reductase gene (MTHFR) polymorphisms and reduced risk of malignant lymphoma Am J Hematol 2004, 77:351-7. 10.1002/ajh.20215 15551285
13. Butcher NJ Boukouvala S Sim E Minchin RF Pharmacogenetics of the arylamine N-acetyltransferases Pharmacogenomics 2002, 2:30-42. 10.1038/ sj.tpj.6500053
14. Grant DM Goodfellow GH Sugamori K Durette K Pharmacogenetics of the human arylamine N-acetyltransferases Pharmacology 2000, 61:204-211. 10.1159/000028402 10971207
15. Hein DW Doll MA Fretland AJ Leff MA Webb SJ Xiao GH Devanaboyina US Nangju NA Feng Y Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms Cancer Epidemiol Biomarkers Prev 2000, 9:29-42. 10667461
16. Venugopal R Jaiswal AK Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:qUinone oxidoreductase1 gene Proc Natl Acad Sci USA 1996, 93:14960-5. 26245 8962164 10.1073/pnas.93.25.14960
17. Larson RA Wang Y Banerjee M Wiemels J Hartford C Le Beau MM Smith MT Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:qUinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia Blood 1999, 94:803-7. 10397748
18. Schulz WA Krummeck A Rösinger I Schmitz-Dräger BJ Sies H Predisposition towards urolithiasis associated with the NQO1 null-allele Pharmacogenetics 1998, 8:453-4. 10.1097/00008571-199810000-00011 9825838
19. Sarmanova J Benesova K Gut I Nedelcheva-Kristensen V Tynkova L Soucek P Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas Hum Mol Genet 2001, 10:1265-73. 10.1093/hmg/10.12.1265 11406608
20. Kerridge I Lincz L Scorgie F Hickey D Granter N Spencer A Association between xenobiotic gene polymorphisms and non-Hodgkin's lymphoma risk Br J Haematol 2002, 118:477-81. 10.1046/j.1365-2141.2002.03606.x 12139735
21. Aydin-Sayitoglu M Hatirnaz O Erensoy N Ozbek U Role of CYP2D6, CYP1A1, CYP2E1, GSTT1, and GSTM1 genes in the susceptibility to acute leukemias Am J Hematol 2006, 81:62-70. 10.1002/ajh.20434 16369971
22. Pakakasama S Mukda E Sasanakul W Kadegasem P Udomsubpayakul U Thithapandha A Hongeng S Polymorphisms of drug-metabolizing enzymes and risk of childhood acute lymphoblastic leukemia Am J Hematol 2005, 79:202-5. 10.1002/ajh.20404 15981231
23. Hayes JD Pulford DJ The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance Crit Rev Biochem Mol Biol 1995, 30:445-600. 10.3109/10409239509083491 8770536
24. Lin HJ Han CY Bernstein DA Hsiao W Lin BK Hardy S Ethnic distribution of the glutathione transferase Mu 1-1 (GSTM1) null genotype in 1473 individuals and application to bladder cancer susceptibility Carcinogenesis 1994, 15:1077-81. 10.1093/carcin/15.5.1077 8200072
25. Hirvonen A Husgafvel-Pursiainen K Anttila S Vainio H The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung Carcinogenesis 1993, 14:1479-81. 10.1093/carcin/14.7.1479 8330369
26. Oude Ophuis MB van Lieshout EMM Roelofs HMJ Peters WHM Manni JJ Glutathione S-transferase M1 and T1 and cytochrome P4501A1 polymorphisms in relation to the risk for benign and malignant head and neck lesions Cancer 1998, 82:936-43. 10.1002/ (SICI)1097-0142(19980301)82:5<936::AID-CNCR20>3.0.CO;2-0 9486585
27. Katoh T Nagata N Kuroda Y Itoh H Kawahara A Kuroki N Ookuma R Bell DA Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma Carcinogenesis 1996, 17:1855-9. 10.1093/carcin/17.9.1855 8824506
28. Brockmöller J Cascorbi I Kerb R Roots I Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk Cancer Res 1996, 56:3915-25. 8752158
29. Shanley SM Chenevix-Trench G Palmer J Hayward N Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma Carcinogenesis 1995, 16:2003-4. 10.1093/carcin/16.8.2003 7634433
30. Farid NR Molecular pathogenesis of thyroid cancer: The significance of oncogenes, tumor suppressor genes, and genomic instability Exp Clin Endocrinol Diabetes 1996, 104:1-12. 8980991
31. De Lellis RA Lloyd RV Heitz PU Tumors of endocrine organs Pathology and Genetics WHO Classification of Tumors, IARC press, Lyon Eng 2004.
32. Simon R Sauter G Tissue micro arrays for miniaturized high throughput molecular profiling of tumors Exp Hematol 2002, 30:1365-1372. 10.1016/ S0301-472X(02)00965-7 12482497
33. Bu R Gutierrez MI Al-Rasheed M Belgaumi A Bhatia K Variable drug metabolism genes in Arab population Pharmacogenomics J 2004, 4:260-6. 10.1038/sj.tpj.6500251 15111988
34. Krajinovic M Labuda D Mathonnet G Labuda M Moghrabi A Champagne J Sinnett D Polymorphisms in genes encoding drugs and xenobiotic metabolizing enzymes, DNA repair enzymes, and response to treatment of childhood acute lymphoblastic leukemia Clin Cancer Res 2002, 8:802-10. 11895912
35. Davies SM Robison LL Buckley JD Tjoa T Woods WG Radloff GA Ross JA Perentesis JP Glutathione S-transferase polymorphisms and outcome of chemotherapy in childhood acute myeloid leukemia J Clin Oncol 2001, 19:1279-1287. 11230469
36. Anderer G Schrappe M Brechlin AM Lauten M Muti P Welte K Stanulla M Polymorphisms within glutathione S-transferase genes and initial response to glucocorticoids in childhood acute lymphoblastic leukaemia Pharmacogenetics 2000, 10:715-726. 10.1097/00008571-200011000-00006 11186134
37. Chiusolo P Reddiconto G Casorelli I Laurenti L Sora F Mele L Annino L Leone G Sica S Preponderance of methylenetetrahydrofolate reductase C677T homozygosity among leukemia patients intolerant to methotrexate Ann Oncol 2002, 13:1915-1918. 10.1093/annonc/mdf322 12453860
38. Naoe T Takeyama K Yokozawa T Kiyoi H Seto M Uike N Ino T Utsunomiya A Maruta A Jin-nai I Kamada N Kubota Y Nakamura H Shimazaki C Horiike S Kodera Y Saito H Ueda R Wiemels J Ohno R Analysis of genetic polymorphism in NQO1, GST-M1, GST-T1, and CYP3A4 in 469 Japanese patients with therapy-related leukemia/myelodysplastic syndrome and de novo acute myeloid leukemia Clin Cancer Res 2000, 6:4091-4095. 11051261
39. Allan JM Wild CP Rollinson S Willett EV Moorman AV Dovey GJ Roddam PL Roman E Cartwright RA Morgan GJ Polymorphism in glutathione S-transferase P1 is associated with susceptibility to chemotherapy-induced leukemia Proc Natl Acad Sci USA 2001, 98:11592-11597. 58774 11553769 10.1073/pnas.191211198
40. Marciniak P Drobnik K Ziemnicka K Gut P Słomski R Sowiński J Transferase S-glutathione class pi gene (GSTP1) polymorphism in thyroid cancer patients Endokrynol Pol 2006, 57:509-15. Polish. 17133316
41. Ho T Zhao C Zheng R Liu Z Wei Q Sturgis EM Glutathione S-transferase polymorphisms and risk of differentiated thyroid carcinomas: A case-control analysis Arch Otolaryngol Head Neck Surg 2006, 132:756-61. 10.1001/archotol.132.7.756 16847185
42. Hernández A Xamena N Gutiérrez S Velázquez A Creus A Surrallés J Galofré P Marcos R Basal and induced micronucleus frequencies in human lymphocytes with different GST and NAT2 genetic backgrounds Mutat Res 2006, 606:12-20. 16621679
43. Stankov K Landi S Gioia-Patricola L Bonora E Volante M Papotti M Romeo G GSTT1 and M1 polymorphisms in Hürthle thyroid cancer patients Cancer Lett 2006, 240:76-82. 10.1016/j.canlet.2005.08.017 16427734
44. Granja F Morari J Morari EC Correa LA Assumpção LV Ward LS GST profiling may be useful in the screening for thyroid nodule malignancy Cancer Lett 2004, 209:129-37. 10.1016/j.canlet.2003.12.013 15159014
45. Gaspar J Rodrigues S Gil OM Manita I Ferreira TC Limbert E Gonçalves L Pina JE Rueff J Combined effects of glutathione S-transferase polymorphisms and thyroid cancer risk Cancer Genet Cytogenet 2004, 151:60-7. 10.1016/j.cancergencyto.2003.09.018 15120911
46. Canbay E Dokmetas S Canbay EI Sen M Bardakci F Higher glutathione transferase GSTM1 0/0 genotype frequency in young thyroid carcinoma patients Curr Med Res Opin 2003, 19:102-6. 10.1185/030079902125001425 12740153
47. Tew KD Glutathione-associated enzymes in anticancer drug resistance Cancer Res 1994, 54:4313-4321. 8044778
48. Strange RC Spiteri MA Ramachandran S Fryer AA Glutathione-S-transferase family of enzymes Mutat Res 2001, 482:21-26. 11535245
49. Strange RC Jones PW Fryer AA Glutathione S-transferase: Genetics and role in toxicology Toxicol Lett 2000, 112-113:357-363. 10.1016/ S0378-4274(99)00230-1
50. Landi S Mammalian class theta GST and differential susceptibility to carcinogens: A review Mutat Res 2000, 463:247-283. 10.1016/ S1383-5742(00)00050-8 11018744
51. Raza H Robin MA Fang JK Avadhani NG Multiple isoforms of mitochondrial glutathione S-transferases and their differential induction under oxidative stress Biochem J 2002, 366:45-55. 1222767 12020353
52. Hernández A Céspedes W Xamena N Surrallés J Creus A Galofré P Marcos R Glutathione S-transferase polymorphisms in thyroid cancer patients Cancer Lett 2003, 190:37-44. 10.1016/ S0304-3835(02)00580-3 12536075
53. Morari CE Leite JLP Granja F da Assumpção LV Ward LS The null genotype of glutathione S-transferase M1 and T1 locus increases the risk for thyroid cancer Cancer Epidemiol Biomarkers Prev 2002, 11:1485-1488. 12433731
54. Rollinson S Levene AP Mensah FK Roddam PL Allan JM Diss TC Roman E Jack A MacLennan K Dixon MF Morgan GJ Gastric marginal zone lymphoma is associated with polymorphisms in genes involved in inflammatory response and antioxidative capacity Blood 2003, 102:1007-11. 10.1182/ blood-2002-12-3803 12676777
55. Chiu BC Kolar C Gapstur SM Lawson T Anderson JR Weisenburger DD Association of NAT and GST polymorphisms with non-Hodgkin's lymphoma: A population-based case-control study Br J Haematol 2005, 128:610-5. 10.1111/j.1365-2141.2004.05358.x 15725081
56. Grimaldi CM Cleary J Dagtas AS Moussai D Diamond B. Estrogen alters thresholds for B cell apoptosis and activation J Clin Invest 2002, 109:1625-33. 151010 12070310
57. Siraj AK Bavi P Abubaker J Jehan Z Sultana M Al-Dayel F Al-Nuaim A Alzahrani A Ahmed M Al-Sanea O Uddin S Al-Kuraya KS Genome-wide expression analysis of Middle Eastern papillary thyroid cancer reveals c-MET as a novel target for cancer therapy J Pathol 2007, 213:190-9. 10.1002/path.2215 17703498
58. Bufalo NE Leite JL Guilhen AC Morari EC Granja F Assumpcao LV Ward LS allelic variants Endocr Relat Cancer 2006, 13:1185-93. 10.1677/ ERC-06-0002 17158763